Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

According to the currently available data from large cohort studies, patients with immuno-inflammatory rheumatic diseases (IIRDs) are at increased risk of infectious complications, including influenza, compared to the general population. Vaccinations are a critical component of their care. However,...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	M. M. Baranova, N. V. Muravyeva, B. S. Belov, M. E. Diatroptov, D. V. Bukhanova
Formaat:	Artikel
Taal:	Russian
Gepubliceerd in:	LLC "Publishing House OKI" 2024-06-01
Reeks:	Антибиотики и Химиотерапия
Onderwerpen:	influenza rheumatoid arthritis ankylosing spondylitis psoriatic arthritis vaccination efficacy immunogenicity safety
Online toegang:	https://www.antibiotics-chemotherapy.ru/jour/article/view/1129

Gelijkaardige items

Immunogenicity, efficacy and safety of the three-valent inactivated influenza split vaccine in patients with ankylosing spondylitis and psoriatic arthritis
door: M. M. Baranova, et al.
Gepubliceerd in: (2024-06-01)

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
door: D. V. Bukhanova, et al.
Gepubliceerd in: (2018-07-01)

Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
door: Alyssa Howren, et al.
Gepubliceerd in: (2025-01-01)

Gait characteristics associated with the foot and ankle in inflammatory arthritis: a systematic review and meta‐analysis
door: Matthew Carroll, et al.
Gepubliceerd in: (2015-01-01)

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line
door: Svedbom A, et al.
Gepubliceerd in: (2017-01-01)

Rheumatoid arthritis and spondyloarthritis prevalence in four European countries - a comparative study
door: Zlatković-Švenda Mirjana, et al.
Gepubliceerd in: (2022-01-01)

Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases
door: Hermine Leroi, et al.
Gepubliceerd in: (2020-05-01)

Comorbidities in inflammatory joint and spine diseases in XXI century
door: I Z Gaydukova, et al.
Gepubliceerd in: (2018-12-01)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
door: Takacs P, et al.
Gepubliceerd in: (2019-01-01)

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
door: Joshua L. Lee, et al.
Gepubliceerd in: (2018-08-01)

The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
door: M. M. Baranova, et al.
Gepubliceerd in: (2021-03-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
door: M. Rossini, et al.
Gepubliceerd in: (2015-03-01)

Hypogonadism in men with inflammatory joint diseases: Frequency and clinical characteristics
door: Taras S. Panevin, et al.
Gepubliceerd in: (2024-06-01)

The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis
door: I. Pantano, et al.
Gepubliceerd in: (2023-03-01)

Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
door: Milena Iwaszko, et al.
Gepubliceerd in: (2021-11-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
door: Viola Sacchi, et al.
Gepubliceerd in: (2010-06-01)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
door: Krzysztof Bonek, et al.
Gepubliceerd in: (2022-04-01)

Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis
door: Santhi Mantravadi, et al.
Gepubliceerd in: (2020-09-01)

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
door: Philip Brenner, et al.
Gepubliceerd in: (2020-02-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
door: E. E. Gubar, et al.
Gepubliceerd in: (2023-08-01)

Nod-like receptors in inflammatory arthritis
door: Sahib Singh Madahar, et al.
Gepubliceerd in: (2024-02-01)

Inflammatory arthritis and eye diseases: a Mendelian randomization study
door: Xinlin Nie, et al.
Gepubliceerd in: (2023-10-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
door: M. Elaine Husni, et al.
Gepubliceerd in: (2022-03-01)

A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study
door: Christian Dejaco, et al.
Gepubliceerd in: (2022-06-01)

SAFETY AND EFFECTIVENESS OF TRI VALENT INACTIVATED SPLIT VIRION INFLUENZA VACCINE IN PATIENTS WITH RHEUMATOID DISORD ERS
door: D. V. Bukhanova, et al.
Gepubliceerd in: (2018-07-01)

The association of relapsing polychondritis and spondylarthritis – three case reports
door: Eleonora Alina Dragomir-Lica, et al.
Gepubliceerd in: (2023-09-01)

Characteristics of patients with psoriatic arthritis in Korea: focusing on axial involvement
door: Hanna Park, et al.
Gepubliceerd in: (2024-01-01)

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
door: Acar M, et al.
Gepubliceerd in: (2018-11-01)

The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
door: Yu. V. Muravyev, et al.
Gepubliceerd in: (2020-05-01)

Adherence to biological therapies in patients with chronic inflammatory arthropathies
door: Noemí Martínez-López de Castro, et al.
Gepubliceerd in: (2019-07-01)

Unraveling immune cell heterogeneity in autoimmune arthritis: insights from single-cell RNA sequencing
door: Sotaro Nakajima, et al.
Gepubliceerd in: (2024-10-01)

Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents
door: Andrea Picchianti-Diamanti, et al.
Gepubliceerd in: (2025-02-01)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
door: Giovanni Cioffi, et al.
Gepubliceerd in: (2021-03-01)

Diagnosis of spondyloarthritis: should we need new criteria?
door: I. Z. Gaidukova, et al.
Gepubliceerd in: (2015-03-01)

Prevalence of spondyloarthritis and its subtypes - are they really comparable?
door: Zlatković-Švenda Mirjana I., et al.
Gepubliceerd in: (2019-01-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
door: R. M. Balabanova, et al.
Gepubliceerd in: (2021-06-01)

Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study
door: Muhammad Haroon, et al.
Gepubliceerd in: (2018-04-01)

Newly diagnosed seropositive rheumatoid arthritis in a 52-year-old man superimposed on long-standing ankylosing spondylitis during secukinumab treatment
door: Jaroslaw Nowakowski, et al.
Gepubliceerd in: (2023-10-01)

Coexistence of rheumatoid arthritis and ankylosing spondylitis
door: Tacjana Anna Barczyńska, et al.
Gepubliceerd in: (2015-12-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
door: T. V. Dubinina, et al.
Gepubliceerd in: (2023-02-01)